Calcium Phosphate Cement As Bone Void Filler

NCT ID: NCT04645186

Last Updated: 2024-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-05

Study Completion Date

2024-11-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational, prospective, non-randomised, post market clinical follow-up study to compile clinical data on performance and safety of the synthetic bone graft substitute and to assess that the performance and safety of the device are maintained until the reaching of its intended use in a commercial clinical setting in long bone and extremity defects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Defects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Calcium Phosphate Cement (CPC)

Evaluation of CPC in long bone \& extremities

bone graft substitute

Intervention Type DEVICE

Filling bone defects in current clinical practice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bone graft substitute

Filling bone defects in current clinical practice

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients requiring bone grafting after post-traumatic or surgically created bone defects afflicting the long bones and extremities.
* Give written informed consent to participate in the study and be willing to comply with the protocol requirements.
* Able to verbalize and differentiate regarding the location and intensity of pain.
* Physical and mental availability to meet the clinical and radiographic follow-up schedule.

Exclusion Criteria

* Serious infection within two months before surgery.
* Active malignancy, Cellulitis, Osteomyelitis, Osteomyelitis, Bone metastasis, Other bone metabolic diseases.
* Primary bone tumors and contraindications in performing an X-ray or CTscan.
* Women of childbearing potential who are, or plan to become, pregnant during the time of the study.
* The subject is unable or not willing to complete follow-up visits and examination for the duration of the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Nova de Lisboa

OTHER

Sponsor Role collaborator

Bioceramed

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nuno A Ribeiro, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital Lusíadas Lisboa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Lusíadas Lisboa

Lisbon, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019.04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.